Terns Pharmaceuticals, Inc.
TERN
Pozycja w akcjach
#3584
Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the... Terns Pharmaceuticals, Inc. is a biopharmaceutical firm currently in the clinical development phase, dedicated to advancing novel small-molecule treatments. Its primary focus lies in developing both standalone agents and combination therapies to address non-alcoholic steatohepatitis (NASH) and obesity. The company's pipeline includes several key drug candidates: TERN-101, a farnesoid X receptor agonist distinguished by its liver-specific distribution and non-bile acid properties, is presently undergoing Phase IIa clinical trials for NASH. TERN-201, a vascular adhesion protein-1 inhibitor, is in Phase Ib clinical studies, also targeting NASH. Terns is also progressing TERN-501, a thyroid hormone receptor beta agonist engineered for improved liver targeting and metabolic resilience, through Phase I clinical trials for NASH. Furthermore, the company is advancing TERN-601, an oral small-molecule Glucagon-Like Peptide-1 receptor agonist program, intended for the management of NASH and various metabolic conditions, including obesity. Established in 2016, Terns Pharmaceuticals maintains its corporate headquarters in Foster City, California.
Cena akcji
$52.95
Ostatnia synchronizacja: 2026-05-15
Kapitalizacja rynkowa
$4.77B
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
552.09%
Kraj
US
Handel Terns Pharmaceuticals, Inc. (TERN)
Kategoria
Healthcare
Historia ceny akcji dla Terns Pharmaceuticals, Inc. (TERN)
Najwyższa cena zamknięcia: $52.95 dnia 2026-05-01
Najniższa cena zamknięcia: $20.53 dnia 2021-02-01
Najniższa cena zamknięcia: $20.53 dnia 2021-02-01
Historia cen akcji firmy Terns Pharmaceuticals, Inc. od 2021 do 2026
Roczna wydajność ceny akcji
| Rok | Wydajność |
|---|---|
| 2026 (TTM) | -1.17% |
| 2025 | 517.55% |
| 2024 | -2.74% |
| 2023 | -12.48% |
| 2022 | 13.79% |
| 2021 | 0.00% |
Cena akcji podobnych firm lub konkurencji
| Firma | Cena akcji | Zmiana 1r% | Kraj |
|---|---|---|---|
| $517.05 | 21.30% |
US
|
|
| $248.00 | 802.15% |
US
|
|
| $138.33 | -3.31% |
AU
|
|
| $883.46 | 5.83% |
NL
|
|
| $752.87 | 7.40% |
CH
|
